The UK Medical Research Council
The Health Foundation UK
The Stroke Association UK
| IST-3 Funding |
IST-3 is an independant, investigator - led trial. It is supported by grants from :
|
|
The UK Medical Research Council |
|
|
|
The Health Foundation UK |
|
|
|
The Stroke Association UK |
|
|
|
Chest, Heart and Stroke Scotland | |
|
|
University of Edinburgh | |
|
|
Norwegian Research Council | |
|
|
AFA Insurances (Sweden) | |
|
|
The Swedish Heart Lung Fund | |
|
|
The National Heart Foundation Australia | |
|
|
Australian NHMRC | |
|
|
The Government of Poland | |
|
|
Internal Medicine Research Fund - Dalhousie University Canada | |
|
|
Swiss National Research Foundation | |
|
|
Swiss Heart Foundation | |
|
|
Swiss National Science Foundation | |
|
|
Umbria Region funding IST-3 Italy |
In the initial double-blind phase, drug and
placebo for the first 300 patients were supplied by Boehringer Ingelheim